Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated (HR) Market Cap

Healthcare Realty Trust Incorporated has a market capitalization of .

No quote data available.

CEO: Peter A. Scott

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1993-05-27

Website: https://www.healthcarerealty.com

Healthcare Realty Trust Incorporated (HR) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.

Analyst Sentiment

61%
Buy

From 11 Active Polls

1Y Forecast: $21.25

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$20

Median

$22

High Bound

$22

Average

$21

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$21.25
▲ +8.14% Upside
Low Target
$20.00
2% Risk
Median Target
$21.50
9% Mid
High Target
$22.00
12% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HEALTHCARE REALTY TRUST INC CLASS (HR) — Investment Overview

🧩 Business Model Overview

Healthcare Realty Trust Inc. operates as a specialized healthcare REIT focused primarily on medical office buildings (MOBs) and related healthcare real estate. The value chain centers on (1) owning and maintaining facilities that house outpatient physician practices, specialty clinics, and medical services, (2) leasing space under multi-year arrangements, and (3) managing the operating and capital requirements of buildings to preserve tenant quality and cash flow.

The core “stickiness” in this model is tenant-level and location-level: healthcare providers depend on physical access for patients, established patient flow, and operational continuity, while MOB landlords depend on long-duration leases, recurring rent streams, and capital programs that keep properties clinically and operationally suitable.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly rent from leased medical office space, with monetisation tied to (1) occupancy and lease-up of available suites, (2) contractual rent escalations and market rent resets, and (3) additional income from property services or reimbursements where structures permit.

Margin drivers are largely structural and asset-specific:

  • Stability of cash rents: Longer lease durations and repeat demand for established locations support more predictable rental income.
  • Lease terms and rent escalators: Contract mechanics can provide inflation responsiveness, depending on the lease language.
  • Property-level expense management: Operating cost discipline and building systems efficiency influence net operating income.
  • Capital allocation quality: Renovations and modernization can protect demand and re-leasing outcomes, but require disciplined timing and cost controls.

🧠 Competitive Advantages & Market Positioning

The principal moat is high barriers to entry at the asset level combined with embedded tenant retention characteristics common to healthcare real estate.

  • Integrated ecosystem / patient-access moat: Healthcare providers benefit from established patient capture, referral patterns, and operational workflow that are difficult to replicate after relocating. This creates effective “switching costs” for tenants even if the economics are contractually lease-based.
  • Location scarcity in healthcare submarkets: MOB demand is tied to demographics, employment centers, and physician catchment areas. Building a comparable portfolio requires time, planning, and local entitlement processes.
  • Operational and capital know-how: Healthcare uses impose higher build-out and compliance needs (space configuration, HVAC requirements, life-safety specifications, and ongoing maintenance), favoring owners with execution capability and vendor relationships.

Competitive benchmarking: Healthcare REIT peers vary by asset type and end-market exposure. Two main comparators include:

  • Medical Properties Trust (MPW): More exposed to hospital-adjacent healthcare real estate and a different tenant/provider mix; HR’s specialization in MOBs typically emphasizes outpatient demand and patient-access characteristics rather than hospital leverage.
  • Welltower (WELL): Broad healthcare real estate focus (including senior living and post-acute components). HR differs by concentrating on MOBs, where rent durability is tied more directly to physician continuity and localized patient flow.
  • Ventas (VTR): More heavily weighted toward senior housing and related healthcare formats. HR’s MOB focus creates different drivers, including outpatient utilization and local specialty clinic growth.

Compared with these rivals, HR’s positioning is more tightly linked to outpatient care infrastructure and medical practice real estate, where tenancy and renewal economics depend on location-anchored access and facility suitability.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is driven by a combination of demographic demand and structural shifts in care delivery:

  • Shift from inpatient to outpatient care: Capacity growth increasingly occurs in physician offices, specialty clinics, and ambulatory settings—supporting sustained demand for MOB space.
  • Aging population and chronic disease prevalence: Higher utilization of outpatient services supports occupancy and leasing opportunities for healthcare space.
  • Expansion of specialty care and diagnostics: Specialty practices and outpatient procedures require dedicated, configurable space and ongoing facility modernization.
  • Healthcare delivery network consolidation: Mergers and multi-site practice models can increase “portfolio leasing” activity and improve lease commitment when systems standardize facility footprints.
  • Capital expenditure cycle and asset modernization: Building improvements can extend economic life, support higher-quality tenants, and reduce downtime during leasing transitions.

⚠ Risk Factors to Monitor

  • Interest rate and refinancing risk: As a REIT, financing conditions affect cost of capital, balance sheet flexibility, and the ability to fund development or renovation programs.
  • Tenant concentration and credit risk: MOB portfolios can experience pressure if tenant practices face reimbursement headwinds, consolidation, or cost squeezes.
  • Lease rollover and re-leasing execution risk: Occupancy stability depends on managing turnover, renovation timelines, and market rent resets.
  • Healthcare reimbursement and regulatory risk: Changes affecting utilization, site-of-care economics, or regulatory requirements can reduce demand for certain outpatient services or alter tenant affordability.
  • Capital intensity and building obsolescence: Healthcare facility requirements can evolve, increasing maintenance and upgrade needs. Poorly timed or under-scoped capex can impair re-leasing prospects.
  • Geographic and demographic variability: MOB demand is local; slower regional growth can affect leasing and renewal outcomes.

📊 Valuation & Market View

Healthcare REIT valuation typically reflects real estate cash flow characteristics rather than classic earnings multiples. Common market frameworks include:

  • EV/EBITDA and cap-rate assumptions: Property-level fundamentals, perceived risk of cash flows, and prevailing capitalization rates influence valuation.
  • AFFO-based metrics: Investors often anchor on cash earnings quality after recurring capital needs, since REITs distribute substantial portions of cash flow.
  • Balance sheet leverage and interest coverage: Debt maturity profile and the cost to refinance shape downside risk and equity risk premium.
  • Portfolio occupancy, rent growth visibility, and lease duration: Higher-quality lease profiles and stable tenant demand typically support a more favorable valuation.

The needle typically moves with changes in occupancy trends, renewal/re-leasing success, costs of capital, and the sustainability of cash flow given tenant credit conditions and capex requirements.

🔍 Investment Takeaway

Healthcare Realty Trust’s long-term investment case rests on owning MOB assets in markets where outpatient care demand is structurally supported, combined with an asset-level moat created by location scarcity, healthcare “switching costs”, and barriers tied to facility build-out requirements and operational execution. The principal determinants of value over a full cycle are rent stability, disciplined capital allocation, and balance sheet resilience through varying interest-rate environments.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q1): Revenue $267.6M; Net income -$0.1M (EPS -$0.0002). Margins improved sharply vs prior quarters: gross margin expanded to 62.3% from negative levels in 2025 (Q4 gross margin -27.7%, Q3 -30.7%, Q2 -36.3%, Q1 -39.4%) and operating margin rose to 55.8% from 5–12% in 2025. QoQ/YoY trends: Revenue declined -6.6% QoQ (from $286.3M in 2025-12-31) and was -10.5% YoY (from $299.0M in 2025-03-31). Net income swung from +$14.4M in Q4 2025 to ~breakeven/very slightly negative in Q1 2026, and from -$44.9M in Q1 2025 to -$0.06M in Q1 2026 (YoY improvement, but not sustained). Over the four-quarter window, profitability quality looks volatile—large gross/operating margin shifts are not supported by consistent net-income strength. Cash flow & capital returns: Operating cash flow was $52.9M in Q1 2026 (vs $132.3M in Q4 2025 and $47.8M in Q1 2025). The company repurchased stock (-$100.0M) and paid dividends (-$83.9M), with net cash essentially flat. Total shareholder returns: With the stock at $18.55 and a 1y_change of +18.15% (below the >20% momentum threshold), shareholder returns appear positive but not exceptional on momentum; dividend yield is ~1.42%. Balance sheet shows equity around $4.49B and total assets ~$9.15B, but liquidity remains thin (cash/current assets are limited)."

Revenue Growth

Caution

Revenue fell -6.6% QoQ (286.3M -> 267.6M) and -10.5% YoY (299.0M -> 267.6M), indicating a weakening demand/volume trend.

Profitability

Neutral

Reported margins improved materially in Q1 2026 (gross margin 62.3%, operating margin 55.8%) versus negative gross margins in 2025 quarters; however, net income is essentially flat/slightly negative (-$0.1M), suggesting volatile earnings quality.

Cash Flow Quality

Neutral

Operating cash flow was solid at $52.9M in Q1 2026 and positive vs Q1 2025 ($47.8M). Capital returns were active (buybacks -$100M, dividends -$83.9M).

Leverage & Balance Sheet

Fair

Non-bank-style leverage metrics show net debt of ~$0.21B at 2026-03-31 versus much higher net debt in 2025 quarters (e.g., ~$4.99B at 2025-03-31), but cash and current assets are still small relative to operating needs; equity is stable around ~$4.49B.

Shareholder Returns

Neutral

Market momentum is positive (+18.15% over 1y, below the >20% boost). Dividend yield is ~1.42% and the company executed meaningful buybacks in the quarter.

Analyst Sentiment & Valuation

Neutral

Price target consensus is ~$19.33 vs $18.55 spot, implying modest upside; without a strong, consistent earnings trend, valuation appeal looks limited.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Q1 2026 delivered a standout leasing and operating quarter for Healthcare Realty 2.0, with >2.0M sq ft of signed leases (290+ leases) and same-store NOI growth of 6.9% (nearly 7%); same-store occupancy reached 92.3% (+110 bps YoY) and same-store margins expanded 60 bps. Growth quality was reinforced by a 93.5% retention rate, annual escalators averaging ~3.1%, and cash leasing spreads at 4.2% (with 25% of leases >5%). Management raised full-year normalized FFO per share guidance by $0.01 to $1.59-$1.65 (midpoint $1.62) and lifted same-store cash NOI growth by 25 bps to 3.75%-4.75%, attributing upside to leasing outcomes and re-leasing spreads. Capital deployment was disciplined: $100M buybacks (with $400M authorization remaining), $18M pro rata JV acquisition, and ~$25M redevelopment investment, backed by $400M delayed-draw term loan and ~$1B liquidity. Key remaining watch item is translating SNO/lease-up gains into occupancy, with an August bond maturity flagged as a potential annualization drag.

AI IconGrowth Catalysts

  • Same-store occupancy momentum: HR 2.0 same-store occupancy improved to 92.3% (+110 bps YoY), supporting near-term FFO/NOI growth
  • Annual escalators on signed leases averaging ~3%+ (3.1% in Q1), highlighted as the primary driver for core earnings growth given ~ $650M same-store NOI
  • Cash leasing spreads: 4.2% in Q1; 1 out of every 4 signed leases with >5% spreads, supporting core growth/NOI uplift
  • High retention rate: 93.5% in Q1, reducing downtime and capex vs new leases and increasing lease IRR/profitability
  • Redevelopment execution: +900 bps sequential gain in redevelopment lease percentage and added two projects with targeted yields (9% to 12%)

Business Development

  • Wellstar (Atlanta): 176,000 sq ft new + renewal across 6 on-campus buildings including a 59,000 sq ft cancer center; renewals average ~5-year term; blended cash leasing spread ~4%
  • Advocate Health (Charlotte): 6 renewal leases totaling 154,000 sq ft; average term >7 years; blended cash leasing spread >5%
  • Trinity Health St. Peter's Hospital (Upstate NY): 64,000 sq ft clinical and surgery center space; average term nearly 6.5 years; annual escalators 3%
  • MUSC Health (Charleston): 3 renewals totaling 55,000 sq ft across 2 buildings; 100% occupancy maintained; average term 9 years; average cash leasing spread ~14%
  • KKR joint venture: management referenced allocating $50M to $100M in 2026 (growth JV) and emphasized 5% NOI exposure currently in JVs

AI IconFinancial Highlights

  • Normalized FFO per share: $0.41 in Q1 (sequentially from $0.40); same-store cash NOI growth 6.9% (nearly 7% reported as all-time high)
  • Same-store margins expanded 60 bps YoY (Q1 same-store occupancy 92.3%)
  • Guidance raised early: full-year normalized FFO per share increased by $0.01 to $1.59-$1.65 (midpoint $1.62); same-store cash NOI growth revised to 3.75% to 4.75% (up 25 bps)
  • Core earnings growth model: 2026 tracking above 5% excluding dilution impact from 2025 dispositions (no explicit tax/tariff impact disclosed in transcript)

AI IconCapital Funding

  • Share repurchases: $100M repurchased in Q1 ($50M in March opportunistically); total YTD $100M or 5.7M shares at weighted avg price $17.38
  • Remaining buyback authorization: $400M capacity remaining
  • Deliberate leverage/capital plan: maintain year-end leverage target in the mid-5x range; balance sheet capacity referenced as ~$100M to $200M entering the year
  • JV acquisition: closed on $18M pro rata acquisition at quarter-end (pro rata share)
  • Redevelopment spend: invested $25M in Q1; commenced 2 new redevelopments with expected cost $31M and additional $35M redevelopment completed in quarter
  • New debt facility: $400M unsecured delayed draw term loan expected to close in May; drawn pricing SOFR + 90 bps; all-in ~4.8% including transaction costs; plan to draw in late July to repay $600M bond maturity; balance funded on line of credit
  • Commercial paper: launched program; ~$250M outstanding; fully backstopped by line of credit; borrowing costs ~40-50 bps lower than line
  • Swaps: extended maturities on $400M swaps to lock SOFR at 3.3% through maturity in 2029
  • Liquidity: after factoring term loan, remaining liquidity on line of credit of ~$1B

AI IconStrategy & Ops

  • Leasing performance: executed 290+ leases totaling >2M sq ft (strongest quarter ever); weighted average lease term nearly 8 years
  • Renewal economics: annual escalators averaged 3.1%; tenant retention 93.5%; 8 single-tenant renewals ~740,000 sq ft with ~10-year average extension reducing lease maturities through end of 2027
  • Signed Not Occupied (SNO) pipeline: 490,000 sq ft SNO referenced in outlook; Q&A cited ~90,000 sq ft SNO, nearly half in lease-up redevelopment bucket
  • Redevelopment specifics: added $25M Tufts Medical Center Boston MOB redevelopment (155,000 sq ft), 100% pre-leased, 10-year term, 3% annual escalators; completed $35M Charlotte 2-MOB adjacent to Novant Health Huntersville, 98% leased; stabilized yield within 9% to 12% target range; move into same-store after full calendar year post-completion
  • Governance/board refresh: Jay Leupp to retire after upcoming annual meeting; remaining directors average tenure <2 years; plan to add a new director later in the year

AI IconMarket Outlook

  • Full-year 2026 guidance (raised): normalized FFO per share $1.59-$1.65 (midpoint $1.62); same-store cash NOI growth 3.75% to 4.75% (up 25 bps)
  • Leasing pipeline outlook: robust new leasing pipeline ~1.4M sq ft and 490,000 sq ft SNO pipeline to drive occupancy gains during remainder of 2026
  • Occupancy target framing: same-store occupancy positioned around 92% to 93% (current 92.3%); total occupancy target stated as approaching 92% to 93% by management commentary

AI IconRisks & Headwinds

  • August bond maturity referenced as a potential drag to annualized FFO (Q&A cut off before full details; only 'drag' and existence of August maturity explicitly noted)
  • Execution risk translating leased but not yet occupied space (SNO/lease-up) into occupancy: management showed leased gains in redevelopment not yet turning into occupancy (900 bps sequential redevelopment lease percentage gain described as not yet fully reflected in occupancy)
  • Occupancy friction expected: management characterized frictional vacancy for outpatient medical as mid-to-high single digits; not modeled as achieving materially above 93% same-store without absorption offsets
  • Interest rate/capital market sensitivity: management cited financing availability and swap rate lock-in but still noted higher 10-year Treasury (4.3%) as backdrop influencing valuation/through-cycle assumptions

Q&A: Analyst Interest

  • Same-store 6.9% conservatism vs repeatability: Management said the quarter benefited from an easier YoY comp, with two key drivers—meaningful same-store occupancy ramp and margin improvements—plus strong leasing. They framed any implied deceleration as an opportunity to raise guidance multiple times rather than true deceleration.
  • How much SNO will matter for occupancy/when to reach targets: Management highlighted that redevelopment disclosures improved to track percent pre-leased, with much of SNO sitting in the lease-up redevelopment bucket. They cited ~900 bps sequential leased gains within redevelopment that hadn’t yet translated into occupancy, plus a strong 1.4M sq ft pipeline.
  • JV depth, partner interest, and outpatient transaction pricing: Management emphasized growth JV focus with KKR as the primary growth structure. Ryan stated private bid momentum continued into 2026 with financing available and noted cap-rate levels—core assets around 5.5% to 6%, and core-plus not much above those levels—supporting JV underwriting.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HR Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Healthcare Realty Trust Incorporated (HR) Financial Profile